Doxycycline Hyclate Tablet, Delayed Release
Product Images NDC 0591-4550

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Doxycycline Hyclate (NDC 0591-4550). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Doxycycline Hyclate Delayed Release Tablets A09013 1

Chemical structure of doxycycline hyclate, showing the molecular arrangement including hydroxyl groups, amide group, and dimethylamine substituent, consistent with the active ingredient doxycycline hyclate in the delayed-release tablet.*

FDA Label Image

Doxycycline Hyclate Delayed Release Tablets A09013 2

Label for Doxycycline Hyclate Delayed-Release Tablets USP 50 mg by Actavis Pharma, Inc. The label states the dosage form as delayed-release tablets with a package count of 120 tablets. It includes administration instructions, storage conditions, and a barcode. Manufacturer details and issuance date (08/2017) are also visible.*

FDA Label Image

Doxycycline Hyclate Delayed Release Tablets A09013 3

Label of Doxycycline Hyclate Delayed-Release Tablets USP, 200 mg, oral tablets. The label indicates 60 tablets per bottle, instructions to not chew tablets, and highlights that each tablet contains specially coated pellets of doxycycline hyclate equivalent to 200 mg of doxycycline. The labeler is Teva Pharmaceuticals USA, Inc., North Wales, PA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.